Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele


						Mean data of patients treated with BTX-A (leak point volume, leak point pressure, and specific capacity at 20 cm H<sub>2</sub>O are referred to baseline values and after the first injection of BTX-A). 

Dataset Papers in Science

tab1

Table 1

Table 1: Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele 

Table 1 | Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele 